<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Peptide.it News</title>
    <link>https://peptide.it/news</link>
    <description>Independent peptide research, regulatory, and market news, tiered by evidence.</description>
    <language>en-us</language>
    <item>
      <title>FDA updates compounding guidance affecting GLP-1 availability</title>
      <link>https://peptide.it/news/fda-glp-1-compounding-guidance</link>
      <guid>https://peptide.it/news/fda-glp-1-compounding-guidance</guid>
      <pubDate>Jun 04 2026 00:00:00 GMT</pubDate>
      <description>New agency guidance narrows when compounding pharmacies may prepare certain GLP-1 and related peptide products, with knock-on effects for supply.</description>
      <category>Regulatory</category>
    </item>
    <item>
      <title>Meta-analysis pools GHRH-analog trials on lean body mass</title>
      <link>https://peptide.it/news/ghrh-analog-meta-analysis</link>
      <guid>https://peptide.it/news/ghrh-analog-meta-analysis</guid>
      <pubDate>Jun 02 2026 00:00:00 GMT</pubDate>
      <description>A new pooled analysis combines randomized trials of growth-hormone-releasing-hormone analogs and reports modest effects on lean mass, with notable limitations.</description>
      <category>Research</category>
    </item>
    <item>
      <title>New cellular-senescence assay renews interest in bioregulators</title>
      <link>https://peptide.it/news/senescence-assay-bioregulators</link>
      <guid>https://peptide.it/news/senescence-assay-bioregulators</guid>
      <pubDate>May 30 2026 00:00:00 GMT</pubDate>
      <description>A preprint describes a faster screening assay for cellular senescence that researchers are using to revisit peptide bioregulators such as epitalon.</description>
      <category>Longevity</category>
    </item>
  </channel>
</rss>